A new trading day began on August 04, 2022, with Viking Therapeutics Inc. (NASDAQ: VKTX) stock priced at $2.86, up 11.58% from the previous day of trading. During the day, the shares moved up to $3.195 and dropped to $2.86 before settling in for the closing price of $2.85. VKTX’s price has ranged from $2.02 to $7.20 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Meanwhile, its annual earnings per share averaged -30.90%. With a float of $68.46 million, this company’s outstanding shares have now reached $76.84 million.
The firm has a total of 17 workers. Let’s measure their productivity.
Viking Therapeutics Inc. (VKTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc. is 0.10%, while institutional ownership is 41.20%. The most recent insider transaction that took place on May 02, was worth 111,195. In this transaction Director of this company bought 45,000 shares at a rate of $2.47, taking the stock ownership to the 111,250 shares.
Viking Therapeutics Inc. (VKTX) Recent Fiscal highlights
This company achieved a return on equity of -24.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to 4.70% growth over the previous five years of trading.
Viking Therapeutics Inc. (NASDAQ: VKTX) Trading Performance Indicators
Here are Viking Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.76, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Viking Therapeutics Inc. (VKTX)
Analysing the last 5-days average volume posted by the [Viking Therapeutics Inc., VKTX], we can find that recorded value of 1.19 million was better than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 32.92%. Additionally, its Average True Range was 0.28.
During the past 100 days, Viking Therapeutics Inc.’s (VKTX) raw stochastic average was set at 66.10%, which indicates a significant increase from 41.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.26% in the past 14 days, which was higher than the 76.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.83, while its 200-day Moving Average is $3.71. Now, the first resistance to watch is $3.30. This is followed by the second major resistance level at $3.41. The third major resistance level sits at $3.63. If the price goes on to break the first support level at $2.96, it is likely to go to the next support level at $2.74. Now, if the price goes above the second support level, the third support stands at $2.63.
Viking Therapeutics Inc. (NASDAQ: VKTX) Key Stats
With a market capitalization of 257.68 million, the company has a total of 76,688K Shares Outstanding. Currently, annual sales are 0 K while annual income is -54,990 K. The company’s previous quarter sales were 0 K while its latest quarter income was -17,430 K.